Corcept Therapeutics (CORT)
$81.12 -5.62% Close Oct 30, 2026 Live
Corcept Therapeutics stock today
Corcept Therapeutics closed at $81.12 on October 30, 2026, down 5.62% on the day. Over the past year it returned +12.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.71 billion.
$50.00$100.00
NovJan 2026MarMayJulSep
| Period | CORT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -29.6% | -0.9% |
| 3 months | -31.4% | +2.1% |
| Year to date | +133.1% | +11.7% |
| 1 year | +12.3% | +12.4% |
| 3 years | +196.8% | +88.5% |
| 5 years | +350.7% | +76.0% |
Key statistics
- Market value
- $8.71B
- P/E (trailing)
- 193.1
- Forward P/E
- 25.7
- Price / sales
- 10.5
- 52-week range
- $32.15 to $123.57
- Next report
- Nov 3, 2026
About Corcept Therapeutics
Pharmaceutical company developing treatments for cortisol-related medical conditions.
Sector: Health Care · Industry: Pharmaceuticals
More on Corcept Therapeutics
- Financials: revenue, earnings and segmentsRevenue +13% in the year to Dec 2025
- Valuation: P/E history and peersP/E 193.1, median 27.1 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $11,740 today
No forecast, no recommendation. This page describes Corcept Therapeutics from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.